Other studies suggested that overexpression of ER chaperones such as BiP/Grp78 and calnexin leads to reduction of β-amyloid peptide, which is involved in the pathogenesis of Alzheimer's disease in vitro (41). This evidence concerns the gene HSPA5 and early-onset autosomal dominant Alzheimer disease.